GRANULES stock
GRANULES is showing a constructive news setup around Pharmaceuticals, with 4 recent stories and improving sentiment breadth.
GRANULES has built a constructive coverage cluster in the last 19 days. The strongest recurring theme is Pharmaceuticals, while the current weighted impact score is +46 from 4 bullish, 0 bearish, and 0 neutral stories across 3 sources.
GRANULES is last saved at ₹799 with a day move of +0.00%. That quote should be read with the article tape: a positive headline only matters if price, volume, and follow-through confirm it; a negative headline matters more when it keeps repeating across multiple publishers.
Granules reported its latest financial results. The company made ₹1137.69 crore in sales and ₹117.6 crore in profit. This information is on record, and we don't have past data to compare it with. This hub keeps the permanent stock view separate from short-lived article pages, so search engines and users get one accumulated view instead of scattered programmatic summaries.
Economic Times · 11 Sept 2026 · 2 min read
Mint · 11 Sept 2026 · 2 min read
Economic Times · 8 Sept 2026 · 2 min read
Mint · 24 Aug 2026 · 2 min read
Economic Times · 19 Jul 2026 · 2 min read
How GRANULES stacks against related names in this news cluster
GRANULES has appeared across 4 recent stories from 3 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.
GRANULES coverage is currently leaning bullish, with 4 bullish, 0 bearish, and 0 neutral analyzed stories in the recent window.
Recent GRANULES coverage is clustering around Pharmaceuticals and Aerospace & Defence. Related names showing up alongside GRANULES include ADANIPORTS, ALLCARGO, ARVIND.
Use this page as a coverage hub for GRANULES: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.
3 recent mentions linked to GRANULES
TopicAerospace & Defence1 recent mentions linked to GRANULES
StockADANIPORTSRelated news cluster with 1 links
Latest storyMixed Cues for GRANULES: Promoter Sells Rs 1,500 Cr Stake; GoldmanThe pharmaceutical sector in India generally benefits from stable domestic demand and export opportu
How retail crowds and channels are talking about GRANULES right now — context for your own research, not a trade call.